Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 12;9(4):545.
doi: 10.3390/children9040545.

Elevated Alpha-Fetoprotein in Infantile-Onset Niemann-Pick Type C Disease with Liver Involvement

Affiliations

Elevated Alpha-Fetoprotein in Infantile-Onset Niemann-Pick Type C Disease with Liver Involvement

Dror Kraus et al. Children (Basel). .

Abstract

Niemann-Pick disease type C (NPC) is a rare autosomal recessive neuro-visceral lipid storage disease. We describe nine cases of infantile-onset NPC with various genetic mutations in the NPC1 gene, which presented with neonatal cholestasis. Serum alpha-fetoprotein (AFP) levels were obtained as part of their workup during the first four months of life. In eight of nine (89%) patients, serum AFP demonstrated elevated levels. Seven infants displayed marked elevations, ranging from 4 to 300 times the upper limit for age-adjusted norms. In most patients, AFP levels peaked during the initial test and declined over time as cholestasis resolved. We conclude that elevated AFP levels are a common, although non-specific, marker for NPC-associated liver disease. These findings demonstrate the benefit of including AFP levels in the workup of neonatal liver disease, especially if there is accompanied cholestasis and if NPC is suspected.

Keywords: Alpha-fetoprotein; Niemann-Pick disease type C; cholestasis; hepatic involvement.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Serum AFP levels in 9 NPC patients which were tested during the first 3 months of life in comparison with age-adjusted norms. * 95th percentile of normal levels according to Lopez-Terrada et al. [18].

References

    1. Patterson M.C., Clayton P., Gissen P., Anheim M., Bauer P., Bonnot O., Marquardt T. Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update. Neurol. Clin. Pract. 2017;7:499–511. doi: 10.1212/CPJ.0000000000000399. - DOI - PMC - PubMed
    1. Yilmaz B.S., Baruteau J., Rahim A.A., Gissen P. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease. Int. J. Mol. Sci. 2020;21:5059. - PMC - PubMed
    1. Patterson M. Niemann-Pick Disease Type, C. GeneReviews®. [(accessed on 1 March 2022)];2000 Available online: https://www.ncbi.nlm.nih.gov/books/NBK1296/
    1. Vanier M.T., Millat G. Niemann-Pick disease type C. Clin. Genet. 2003;64:269–281. doi: 10.1034/j.1399-0004.2003.00147.x. - DOI - PubMed
    1. Carstea E.D., Polymeropoulos M.H., Parker C.C., Detera-Wadleigh S.D., O’Neill R.R., Patterson M.C., Goldin E., Xiao H., Straub E.R., Vanier M.T. Linkage of Niemann-Pick disease type C to human chromosome 18. Proc. Natl. Acad. Sci. USA. 1993;90:2002–2004. doi: 10.1073/pnas.90.5.2002. - DOI - PMC - PubMed

LinkOut - more resources